HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

BACKGROUND: This study aimed to evaluate the predictive values of hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) levels in 171 Chinese patients with chronic hepatitis B who received a 48-week course of pegylated interferon alfa-2b therapy at 1.5 mcg/kg. METHODS: HBsAg, HBeAg,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Virol J
Main Authors: Yang, Song, Xing, Huichun, Wang, Yuming, Hou, Jinlin, Luo, Duande, Xie, Qing, Ning, Qin, Ren, Hong, Ding, Huiguo, Sheng, Jifang, Wei, Lai, Chen, Shijun, Fan, Xiaoling, Huang, Wenxiang, Pan, Chen, Gao, Zhiliang, Zhang, Jiming, Zhou, Boping, Chen, Guofeng, Wan, Mobin, Tang, Hong, Wang, Guiqiang, Yang, Yuxiu, Xu, Dongping, Dong, Peiling, Wang, Qixin, Wang, Jue, Bognar, Fernando A., Xu, Daozhen, Cheng, Jun
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084370/
https://ncbi.nlm.nih.gov/pubmed/27793166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-016-0640-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares